NASDAQ: BLTE
Belite Bio Inc Stock Ownership - Who owns Belite Bio?

Insider buying vs selling

Have Belite Bio Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Hendrik Peter SchollChief Medical Officer2026-06-184,861$145.44
$706.96kSell
Hendrik Peter SchollChief Medical Officer2026-06-183,748$144.66
$542.19kSell
Hendrik Peter SchollChief Medical Officer2026-06-1896$143.90
$13.81kSell
Hendrik Peter SchollChief Medical Officer2026-06-181,199$146.25
$175.35kSell
Hendrik Peter SchollChief Medical Officer2026-06-1896$147.11
$14.12kSell
Hendrik Peter SchollChief Medical Officer2026-06-16540$140.58
$75.91kSell
Hendrik Peter SchollChief Medical Officer2026-06-163,140$139.57
$438.26kSell
Hendrik Peter SchollChief Medical Officer2026-06-162,054$137.61
$282.64kSell
Hendrik Peter SchollChief Medical Officer2026-06-16784$138.18
$108.33kSell
Hendrik Peter SchollChief Medical Officer2026-06-161,035$145.02
$150.10kSell

1 of 13

BLTE insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BLTE insiders and whales buy or sell their stock.

BLTE Shareholders

What type of owners hold Belite Bio Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Darwin Global Management Ltd7.77%3,057,412$448.31MInstitution
Paradigm Biocapital Advisors LP2.83%1,114,784$163.46MInstitution
Ubs Group Ag1.95%768,359$112.66MInstitution
Rtw Investments LP1.82%715,332$104.89MInstitution
Millennium Management LLC1.45%570,088$83.59MInstitution
Holocene Advisors LP1.26%494,495$72.51MInstitution
Eventide Asset Management LLC0.91%357,650$52.44MInstitution
Deerfield Management Company LP0.77%304,013$44.58MInstitution
Price T Rowe Associates Inc0.72%281,805$41.32MInstitution
Haoyuan Chuang0.52%205,264$30.10MInsider

1 of 3

BLTE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BLTE23.17%1.05%Net SellingNet Selling
ERAS76.07%23.93%Net Buying
CRSP69.13%30.87%Net BuyingNet Selling
XENE97.56%2.44%Net SellingNet Selling
LEGN25.86%0.15%Net SellingNet Selling

Belite Bio Stock Ownership FAQ

Who owns Belite Bio?

Belite Bio (NASDAQ: BLTE) is owned by 23.17% institutional shareholders, 1.05% Belite Bio insiders, and 75.78% retail investors. Haoyuan Chuang is the largest individual Belite Bio shareholder, owning 205,264.00 shares representing 0.52% of the company. Haoyuan Chuang's Belite Bio shares are currently valued at $30.10M.

If you're new to stock investing, here's how to buy Belite Bio stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.